| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print February 18, 2003
Department of Research, University Hospital Basel, Basel 4031
Corresponding Author: Markus.Heim{at}unibas.ch
STAT1 (Signal Transducer and Activator of Transcription) and STAT3 are activated by overlapping but distinct sets of cytokines. STATs are recruited to the different cytokine receptors through their SH2 domains that make highly specific interactions with phosphotyrosine docking sites on the receptors. We used a degenerate phosphopeptide library synthesized on 35
J. Biol. Chem, 10.1074/jbc.M300261200
Submitted on January 9, 2003
Revised on February 14, 2003
Accepted on February 18, 2003
Characterization of phosphopeptide motifs specific for the src homology 2 (SH2) domains of signal transducer and activator of transcription 1 (STAT1) and STAT3
m TentaGel beads and fluorescence activated bead sorting to determine the sequence specificity of the peptide-binding sites of the SH2 domains of STAT1 and STAT3. The large bead library allowed not only peptide sequencing of pools of beads, but also of single beads. The method was validated through surface plasmon resonance measurements of the affinities of different peptides to the STAT SH2 domains. Furthermore, when selected peptides were attached to a truncated erythropoietin receptor and stably expressed in DA3 cells, activation of STAT1 or STAT3 could be achieved by stimulation with erythropoietin. The combined analysis of pool sequencing, the individual peptide sequences and plasmon resonance measurements allowed the definition of SH2 domain binding motifs. STAT1 preferentially binds peptides with the motif phosphotyrosine - (aspartic acid/glutamic acid) – (proline/arginine) – (arginine/proline/glutamine), whereby a negative charged amino acid at +1 excludes a proline at +2 and vice versa. STAT3 preferentially binds peptides with the motif phosphotyrosine-(basic or hydrophobic)–(proline or basic)–glutamine. For both STAT1 and STAT3, specific high affinity phosphopeptides were identified that can be used for the design of inhibitory molecules.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Huang, L. Li, C. Wu, D. Schibli, K. Colwill, S. Ma, C. Li, P. Roy, K. Ho, Z. Songyang, et al. Defining the Specificity Space of the Human Src Homology 2 Domain Mol. Cell. Proteomics, April 1, 2008; 7(4): 768 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ni, C. Zhao, G.-S. Feng, R. F. Paulson, and P. H. Correll A Novel Stat3 Binding Motif in Gab2 Mediates Transformation of Primary Hematopoietic Cells by the Stk/Ron Receptor Tyrosine Kinase in Response to Friend Virus Infection Mol. Cell. Biol., May 15, 2007; 27(10): 3708 - 3715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shao, X. Xu, N. Jing, and D. J. Tweardy Unique structural determinants for stat3 recruitment and activation by the granulocyte colony-stimulating factor receptor at phosphotyrosine ligands 704 and 744. J. Immunol., March 1, 2006; 176(5): 2933 - 2941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Martens, G. Uzan, M. Wery, R. Hooghe, E. L. Hooghe-Peters, and A. Gertler Suppressor of Cytokine Signaling 7 Inhibits Prolactin, Growth Hormone, and Leptin Signaling by Interacting with STAT5 or STAT3 and Attenuating Their Nuclear Translocation J. Biol. Chem., April 8, 2005; 280(14): 13817 - 13823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Qing and G. R. Stark Alternative Activation of STAT1 and STAT3 in Response to Interferon-{gamma} J. Biol. Chem., October 1, 2004; 279(40): 41679 - 41685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Jing, Y. Li, W. Xiong, W. Sha, L. Jing, and D. J. Tweardy G-Quartet Oligonucleotides: A New Class of Signal Transducer and Activator of Transcription 3 Inhibitors That Suppresses Growth of Prostate and Breast Tumors through Induction of Apoptosis Cancer Res., September 15, 2004; 64(18): 6603 - 6609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dreuw, S. Radtke, S. Pflanz, B. E. Lippok, P. C. Heinrich, and H. M. Hermanns Characterization of the Signaling Capacities of the Novel gp130-like Cytokine Receptor J. Biol. Chem., August 20, 2004; 279(34): 36112 - 36120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shao, X. Xu, M.-A. A. Mastrangelo, N. Jing, R. G. Cook, G. B. Legge, and D. J. Tweardy Structural Requirements for Signal Transducer and Activator of Transcription 3 Binding to Phosphotyrosine Ligands Containing the YXXQ Motif J. Biol. Chem., April 30, 2004; 279(18): 18967 - 18973. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
